Staley Brod
Neurology · Milwaukee, WINPI 1740217322
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $762,189 of the $1,003,949 with a category attached, or 75.9%. 15 manufacturers reported payments, led by EMD Serono, Inc. at 58.7% of the total. Reporting peaked in 2023 at $237,628 and has fallen 75.6% since, to $58,067 in 2025. Among neurology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,136 payments — averaging $883.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$589K
- AstraZeneca$200K
- Sanofi$119K
- ANI Pharmaceuticals, Inc.$46K
- Mallinckrodt Hospital Products Inc.$22K
- Merck Kgaa$14K
- plus $14K from 9 others
Across 63 payments — averaging $5140.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$211K
- Sanofi$77K
- EMD Serono, Inc.$30K
- Mallinckrodt Hospital Products Inc.$5K
What the payments were for
- Consulting fees$93,2239%
- Speaking & faculty fees$762,18976%
- Travel & lodging$117,89312%
- Food & beverage$30,5963%
- Education$480%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EMD Serono, Inc. | 695 | $589,466 |
| AstraZeneca | 179 | $200,151 |
| Sanofi | 145 | $119,287 |
| ANI Pharmaceuticals, Inc. | 52 | $45,681 |
| Mallinckrodt Hospital Products Inc. | 25 | $21,772 |
| Merck Kgaa | 3 | $14,017 |
| Mallinckrodt Enterprises LLC | 5 | $9,578 |
| Novartis | 14 | $1,360 |
| Johnson & Johnson | 1 | $1,320 |
| Sanofi-aventis U.S. LLC | 10 | $406 |
| Sentynl Therapeutics, Inc. | 1 | $373 |
| Bristol Myers Squibb | 3 | $271 |
| Roche Products Limited | 1 | $126 |
| TG Therapeutics, Inc. | 1 | $125 |
| Boston Scientific | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,003,949 in reported general payments places this provider in the 95th percentile of 308 neurology providers in Wisconsin.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Baclofen | 21 | $819 |
Paid to pharmacies, not to this prescriber.
Other neurology in Milwaukee
- Bhupendra KhatriMilwaukee$2.5M
- Ahmed ObeidatMilwaukee$1.9M
- Sam HooshmandMilwaukee$229K
- Fallon SchloemerMilwaukee$48K
- Thulasirman RavichandranMilwaukee$47K
- Julia CollinsMilwaukee$21K
- Ryan BrennanMilwaukee$20K
- Elise JohnsonMilwaukee$11K
- Janel SchneiderMilwaukee$9K
- Teresa LeeMilwaukee$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.